PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73295-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)73295-8/fulltext
Title :
PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73295-8&doi=10.1016/S1098-3015(11)73295-8
First page :
A549
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1453